Thryv Therapeutics Licenses a New Class of SGK1 Inhibitors from Spain's CSIC and Universidad Autónoma de Madrid, Extending Its Platform into Neurodegenerative Disease

American Regent, Inc. Issues Voluntary Nationwide Recall of Three Lots of Epinephrine Injection, USP 30 mg/30 mL (1 mg/mL) Due to the Presence of Particulate Matter and Lack of Assurance of Sterility

Enliven Therapeutics to Present at Upcoming Investor Conferences

Legionella present in nearly 20% of water samples, new test results found

'NORMAL' PSA ISN'T ALWAYS 'OK,' NOTES PROTON THERAPY PROVIDER MARKING NATIONAL PROSTATE CANCER AWARENESS MONTH